Evidence map›Paper›PMID 28480485›Full record

ArticleInternational journal of bipolar disorders2017

Long-term lithium treatment in bipolar disorder: effects on glomerular filtration rate and other metabolic parameters.

Leonardo Tondo, Maria Abramowicz, Martin Alda, Michael Bauer, Alberto Bocchetta, Lorenza Bolzani, Cynthia V Calkin, Caterina Chillotti, Diego Hidalgo-Mazzei, Mirko Manchia and 17 more

Open access · goldAbstract read
In one paragraph

Article in International journal of bipolar disorders, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 121 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. A one-compartment model provides benchmark Lithium dose prediction.Journal of psychopharmacology (Oxford, England) · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. [Lithium and its impact on renal function. Recommendations for practice, especially for older patients].Neuropsychiatrie : Klinik, Diagnostik, Therapie und Rehabilitation : Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater · 2025
    Review
  11. Review
  12. Observational
  13. Article
  14. Article
  15. Lithium: current state of the art and future directions.International journal of bipolar disorders · 2024
    Review
  16. What Patients with Bipolar Disorder Need to Know about Lithium.Pharmaceuticals (Basel, Switzerland) · 2024
    Review
  17. Review
  18. Lithium: how low can you go?International journal of bipolar disorders · 2024
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 19 institutions in 8 countries.

Leonardo TondoDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA. Ltondo@aol.com.
Maria AbramowiczDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
Martin AldaDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Michael BauerDepartment of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Alberto BocchettaDepartment of Biomedical Sciences, University of Cagliari, Cagliari, Italy.
Lorenza BolzaniViarnetto Psychiatric Clinic, Lugano, Switzerland.
Cynthia V CalkinDepartment of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Caterina ChillottiUnit of Clinical Pharmacology, Azienda Ospedaliero-Universitaria, Cagliari, Italy.
Diego Hidalgo-MazzeiHospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Mirko ManchiaSection of Psychiatry, Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Bruno Müller-OerlinghausenFreie Universität Berlin, Charité Universitäts-Medizin, Berlin, Germany.
Andrea MurruHospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Giulio PerugiDepartment of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa & Institute of Behavioral Science, Pisa, Italy.
Marco PinnaLucio Bini Mood Disorders Centers, Cagliari and Rome, Italy.
Giuseppe QuarantaDepartment of Experimental and Clinic Medicine, Section of Psychiatry, University of Pisa & Institute of Behavioral Science, Pisa, Italy.
Daniela ReginaldiLucio Bini Mood Disorders Centers, Cagliari and Rome, Italy.
Andreas ReifDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt-am-Main, Germany.
Philipp RitterDepartment of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Janusz K RybakowskiDepartment of Adult Psychiatry, Poznan University of Medical Sciences, Poznan, Poland.
David SaigerDepartment of Psychiatry, Charité Universitäs-Medizin, Berlin, Germany.
Gabriele SaniNeSMOS Department, 'Sapienza' University and Lucio Bini Mood Disorders Center, Rome, Italy.
Valerio SelleDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA.
Thomas StammDepartment of Psychiatry, Charité Universitäs-Medizin, Berlin, Germany.
Gustavo H VázquezThe International Consortium for Mood & Psychotic Disorders Research, MRC 306, McLean Hospital, 115 Mill Street, Belmont, MA, 02478-9106, USA.
Julia VeehDepartment of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Frankfurt-am-Main, Germany.
Eduard VietaHospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Spain.
Ross J BaldessariniDepartment of Psychiatry, Harvard Medical School, Boston, MA, USA.
Dalhousie University · CACharité - Universitätsmedizin Berlin · DEClinica Luganese Moncucco · CHPoznan University of Medical Sciences · PLTU Dresden · DEUniversity of Pisa · ITAzienda Ospedaliero-Universitaria Cagliari · ITCentro de Investigación Biomédica en Red de Salud Mental · ESConsorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESGoethe University Frankfurt · DEHarvard University · USMcLean Hospital · USMedizinische Hochschule Brandenburg Theodor Fontane · DESapienza University of Rome · ITUniversitat de Barcelona · ESUniversity Hospital Frankfurt · DEUniversity of Cagliari · ITUniversity of Padua · ITUniversity of Palermo · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundConcerns about potential adverse effects of long-term exposure to lithium as a mood-stabilizing treatment notably include altered renal function. However, the incidence of severe renal dysfunction; rate of decline over time; effects of lithium dose, serum concentration, and duration of treatment; relative effects of lithium exposure vs. aging; and contributions of sex and other factors all remain unclear.

methodsAccordingly, we acquired data from 12 collaborating international sites and 312 bipolar disorder patients (6142 person-years, 2669 assays) treated with lithium carbonate for 8-48 (mean 18) years and aged 20-89 (mean 56) years. We evaluated changes of estimated glomerular filtration rate (eGFR) as well as serum creatinine, urea-nitrogen, and glucose concentrations, white blood cell count, and body-mass index, and tested associations of eGFR with selected factors, using standard bivariate contrasts and regression modeling.

resultsOverall, 29.5% of subjects experienced at least one low value of eGFR (<60 mL/min/1.73 m LIMITATIONS: Control data for age-matched subjects not exposed to lithium were lacking.

conclusionsLong-term lithium treatment was associated with gradual decline of renal functioning (eGFR) by about 30% more than that was associated with aging alone. Risk of subnormal eGFR was from 18.1% (≥2 low values) to 29.5% (≥1 low value), requiring about 30 years of exposure. Additional risk factors for low eGFR were higher serum lithium level, longer lithium treatment, lower initial eGFR, and medical comorbidity, as well as older age.

Indexed as

Blood urea nitrogenBody-mass indexCreatinineeGFRGlomerular filtration rateGlucoseLithiumStaging of renal functionWhite blood cell count

Identifiers

PMID28480485
PMCPMC5537163
OpenAlexW2610823330

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.